Immunogenicity of a BNT162b2 vaccine booster in health-care workers.

Saiag, Esther; Goldshmidt, Hanoch; Sprecher, Eli; Ben-Ami, Ronen; Bomze, David

Saiag, Esther; Goldshmidt, Hanoch; Sprecher, Eli; Ben-Ami, Ronen; Bomze, David.

Afiliação

Saiag E; Department of Information Systems and Operations, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Goldshmidt H; Division of Clinical Laboratories, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Sprecher E; Division of Dermatology, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Ben-Ami R; Department of Infectious Diseases and Infection Control, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Bomze D; Division of Dermatology, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.

Lancet Microbe ; 2(12): e650, 2021 12.

Article em En | MEDLINE | ID: mdl-34661180

Assuntos

Vacina BNT162; Vacinas; Vacinas contra COVID-19/uso terapêutico; Humanos; SARS-CoV-2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vacinas / Vacina BNT162 Limite: Humans Idioma: En Revista: Lancet Microbe Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google